ArticleCancers2020

Preclinical Evaluation of the Novel Small-Molecule MSI-N1014 for Treating Drug-Resistant Colon Cancer via the LGR5/β-catenin/miR-142-3p Network and Reducing Cancer-Associated Fibroblast Transformation.

Vijesh Kumar Yadav et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.